CellSource Co (TSE:4880) Change In Receivables : 円0 Mil (TTM As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is CellSource Co Change In Receivables?

CellSource Co's change in receivables for the quarter that ended in Jan. 2024 was 円0 Mil. It means CellSource Co's Accounts Receivable stayed the same from Oct. 2023 to Jan. 2024 .

CellSource Co's change in receivables for the fiscal year that ended in Oct. 2023 was 円293 Mil. It means CellSource Co's Accounts Receivable declined by 円293 Mil from Oct. 2022 to Oct. 2023 .

CellSource Co's Accounts Receivable for the quarter that ended in Jan. 2024 was 円324 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CellSource Co's Days Sales Outstanding for the three months ended in Jan. 2024 was 25.21.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CellSource Co's liquidation value for the three months ended in Jan. 2024 was 円4,201 Mil.

CellSource Co Change In Receivables Historical Data

The historical data trend for CellSource Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellSource Co Change In Receivables Chart

CellSource Co Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Receivables

Get a 7-Day Free Trial

-3.84

-91.78

-83.48

-346.34

293.05

CellSource Co Quarterly Data
	Oct18	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

CellSource Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

CellSource Co (TSE:4880) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CellSource Co's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	324.238	/	1173.516	*	91
=	25.21

2. In Ben Graham's calculation of liquidation value, CellSource Co's accounts receivable are only considered to be worth 75% of book value:

CellSource Co's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4678.757	-	846.642	+	0.75 * 324.238	+	0.5 * 251.833
=	4,201

CellSource Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of CellSource Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CellSource Co (TSE:4880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSource Co Ltd (TSE:4880) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002

Website

https://www.cellsource.co.jp

CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.

CellSource Co (TSE:4880) Headlines

No Headlines